1. Home
  2. NAOV

as 12-18-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Industrial Specialties

Nasdaq

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

Founded: 2003 Country:
United States
United States
Employees: N/A City: ELMSFORD
Market Cap: 1.5M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 706.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.22 EPS Growth: N/A
52 Week Low/High: $0.46 - $1.52 Next Earning Date: 11-14-2024
Revenue: $3,291,000 Revenue Growth: 227.79%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

NAOV Daily Stock ML Predictions

Share on Social Networks: